According to Galectin Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$53.99 Million a decrease over its 2022 earnings that were of -S$50.98 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.